We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA Ophthalmology |

Highlights FREE

JAMA Ophthalmol. 2016;134(1):7. doi:10.1001/jamaophthalmol.2015.3208.
Text Size: A A A
Published online


Avery and Gordon expand on analyses evaluating the systemic safety of intravitreous anti–vascular endothelial growth factor injections in patients with diabetic macular edema by investigating a subgroup of these patients with monthly treatment for 2 years. Of 1126 articles reviewed, 4 remained after removing duplicates and those without treatment data for 2 years: 2 trials using monthly aflibercept and 2 using monthly ranibizumab. The primary evaluation combined the monthly aflibercept and the 0.5-mg ranibizumab arms and yielded an increased risk for death compared with sham and laser treatments. Analysis including monthly aflibercept and 0.5-mg ranibizumab yielded an increased risk for cerebrovascular accidents and vascular death.

Chan and colleagues examine the magnitude at which strabismus is detectable by lay observers in an ethnically diverse set of images. Among photographs of 12 ethnically diverse models simulated to have strabismus from esotropia of 21 prism diopters (∆) to exotropia of 21∆, in white and black models, the threshold allowing a 70% positive detection rate was higher for esotropia than for exotropia. For white models, the threshold was 23.2∆ for esotropia and 13.5∆ for exotropia. For black models, the threshold was 20.8∆ for esotropia and 16.3∆ for exotropia. Asian models showed an opposite trend, with the threshold allowing a 70% positive detection rate for esotropia (14.3∆) being lower than that for exotropia (20.9∆).

Because fluoroquinolones are the most commonly prescribed antibiotic class in the outpatient setting and reports have implicated an association between oral fluoroquinolones and an increased risk of uveitis, Sandhu and colleagues determine the hazard of uveitis with oral fluoroquinolone use in a cohort study conducted using medical claims data. A total of 843 854 individuals receiving a fluoroquinolone and 3 543 797 a β-lactam were included in the analysis. After controlling for age, race, and sex using multivariate analysis, no hazard for developing uveitis at the 30-, 60-, or 90-day observation windows was seen. Moxifloxacin produced an increased hazard for uveitis at every point. These data do not support an association between oral fluoroquinolone use and uveitis. Instead, this study showed an association between oral fluoroquinolone use and the risk for uveitis-associated systemic illnesses.

Schuermeyer and colleagues evaluate depression, anxiety, and decision regret before and after testing to estimate uveal melanoma prognosis. In a case series of 96 patients with uveal melanoma who underwent prognostication at the time of primary therapy, the mean (SD) Hospital Anxiety and Depression Scale (HADS) anxiety score at baseline (7.4 [4.0]) was higher than at 3 months (5.4 [3.7]) or 12 months (4.7 [3.4]) and decreased with older age. The decision regret score was associated with the baseline HADS depression score, and HADS depression score increased with baseline HADS anxiety score.




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.